AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $24.27
- 52-wk low
- $8.65
- Prev close
- $15.67
- Mkt cap
- $1.06B
- Beta
- 0.79
- P/S
- 17916.0x
Smart money
Earnings
Earnings came in 25.8% below what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $0 | $59.0K | $0 | $0 |
| Cost of what it sold | $10.0M | $16.0K | $17.0K | — |
| Gross profit | -$10.0M | $59.0K | -$17.0K | — |
| What it spent | ||||
| Research and development | $13.6M | $13.3M | $14.0M | $23.4M |
| Sales and admin | $5.6M | $6.2M | $6.9M | $8.0M |
| Other operating costs | -$10.0M | $381.0K | — | — |
| Total operating expenses | $9.2M | $19.8M | $20.9M | $31.5M |
| What was left | ||||
| Operating profit | -$19.2M | -$19.7M | -$20.9M | -$31.5M |
| Profit before tax | -$30.6M | -$13.6M | -$19.6M | -$36.3M |
| Tax | $11.0K | $130.0K | $12.0K | $18.0K |
| Net profit | -$30.6M | -$13.7M | -$19.6M | -$36.4M |
| EBITDA | -$30.6M | -$13.6M | -$19.6M | -$36.3M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
24 articles · 7 days
Coverage is mixed
Tone of tracked coverage
Avalo Therapeutics (AVTX) CMO sells 1,000 shares in plan
NeutralAug 20Avalo Therapeutics (AVTX) CFO sells 72K shares in 10b5-1 trades
Leans bearishAug 19Avalo Therapeutics (NASDAQ: AVTX) insider lines up new stock sale after $74K August trade
NeutralAug 18
